Shanghai, China

Houcong Jin

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Hello! I'm glad to assist you with the article about inventor Houcong Jin.

Title: Innovation Spotlight: Houcong Jin - Pioneer in PD-L1 Antibodies

Introduction:

Houcong Jin, a renowned inventor based in Shanghai, China, is making waves in the field of biopharmaceuticals with his groundbreaking research and patents.

Latest Patents:

One of his latest patents includes a PD-L1 antibody and its medical applications. This invention focuses on the development of chimeric and humanized antibodies for the treatment of PD-L1 mediated diseases, particularly in the realm of anti-cancer drugs.

Career Highlights:

With a portfolio of two patents, Houcong Jin has demonstrated expertise in the field of biopharmaceutical innovation. His contributions have the potential to revolutionize cancer treatment protocols and improve patient outcomes.

Collaborations:

Houcong Jin has collaborated with esteemed companies such as Suzhou Suncadia Biopharmaceuticals Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His teamwork with industry experts like Xiangdong Qu and Qiyue Hu has further solidified his position as a key player in the biopharmaceutical innovation landscape.

Conclusion:

In conclusion, inventor Houcong Jin's dedication to advancing PD-L1 antibodies and their medical applications underscores his commitment to driving innovation and improving healthcare globally. His collaborative efforts and groundbreaking patents are paving the way for novel treatments in the field of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…